Balancing IP Rights and Children’s Right to Health
The WHO has highlighted alarming statistics. Millions of children suffer from preventable and treatable diseases, even though affordable treatment exists. Children’s right to health is recognized in several United Nations and international agreements. The growing economic power of multinational enterprises (MNEs) and pharmaceutical giants raises new questions. Many ask whether these private, non‑state entities have an obligation to ensure children’s right to health.
